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Effects of Phthalic Acid Esters (PAEs) on
the Neonate and Aspects of Teratogenic
Actions
by J. A. Thomas,* D. B. Wienckowski,* B. A. Gillies,*
M. J. Thomas,t and E. J. Youkilis*
A review ofthe literature reveals that several different phthalic acid esters (PAEs) are capable ofcausing
testicular damage. Phthalate-induced zinc deficiency is consistent with germinal epithelial damage. Among
experimental animals, mice perhaps show the greatest sensitivity to phthalate-induced terata, but high
doses/exposure are required. Little toxicologic information is available with regard to phthalate-induced
effects upon the neonate.
Introduction
During the past few years there have been a number
ofreview articles pertaining to the biologic effects ofthe
phthalic acid esters (PAE) (1-3). In 1981, the National
Toxicology Program and the U.S. Interagency Regula-
tory Liaison Group sponsored a Conference on Phthal-
ates. A host ofU.S. governmental bioassays and reports
pertaining to the biologic and possibly the carcinogenic
actions of some ofthe phthalates have been cited (4). In
many respects this International Conference on the
Phthalic Acid esters is an outgrowth ofearly conferences
and the continuing research interests in assessing the
biological effects ofthese chemicals. Several laboratories
around the world continue to explore the action(s) ofthe
phthalates on a number ofphysiologic systems. There is
verylittleinformationabouttheeffectsofthesechemicals
upon the neonate or upon the young. Some information
is, however, available astothepossibleteratogenicactions
of certain of the phthalate. Some phthalates appear to
be more fetotoxic or embryotoxic than others. Generally,
there also appear to be age-related differences with re-
spect to PAE-induced toxicity, but no studies have fo-
cused specifically upon the effects of these plasticizers
on the neonate. Of the large number of commercially
available PAE, diethylhexyl phthalate (DEHP) seems to
have received the most scientific or toxicologic investi-
gation.
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Teratology
Earlierreviews (1-8) discussed theteratogenic effects
ofsome ofthe phthalates and related chemicals. Though
PAEs in general seem to require high doses to trigger
embryotoxic actions, some appeartobe more teratogenic
than others.
Some phthalates, in particular DEHP and MEHP, re-
portedly exertadverse effects onthe femalereproductive
system. While the teratogenic effects ofselected phthal-
ates have been more thoroughly discussed byTomita (9),
a brief summary of the literature pertaining to DEHP
and/or MEHP is depicted in Table 1. Indeed, the rodent
has received the most widespread investigation. Al-
though there may be species differences, some of the
variation in response to the phthalates could be due to
differences in experimental protocols, including routes of
administration, and duration ofexposure and doses (Ta-
bles 2 and 3). Several other investigations, however, have
failed to disclose any conclusive teratogenic actions, and
based on the incidence ofstillborn pups, a comparison of
the litters born, the number of litters per female, and
the size of the litters. DEHP was concluded to be non-
teratogenic in rats (1).
Renewed interest in the tertogenicity of PAEs oc-
curred in 1970 when Bower et al. (11) reported that di-
butoxyethyl phthalate caused congenital malformations
in chick embryos. Other laboratories, (12,13) also re-
ported an increase in the levels of fetal resorptions in
rats after the administration of high doses of DEHP
Different phthalates (dimethyl, diethyl, dibutyl, diiso-
butyl, dimethoxyethyl, and butylcarbobutoxymethylTHOMAS ETAL.
Table 1. Summary of literature on the teratogenic effects of
DEHP/MEHP.
Species No. of studies Teratogenic Nonteratogenic
Mouse 9 7a 2
Rat 8 4 4
Rabbit 1 0 1
aIncludes one study reporting decreased fetal weights only.
phthalate) were studied by Singh et al. (13,14) who re-
ported an increased incidence of skeletal anomalies in
neonatal rats. Singh et al. (14,15) later reported that the
IP administration ofDEHP to male mice caused feto- or
embryotoxicity in females. In addition there was an in-
creased incidence of resorption when comparing female
controls mated with non-PAE-treated male mice.
Nikonorow et al. (16) reported that the oral adminis-
tration of DEHP caused a significant reduction in pla-
cental weights. This finding led the authors to conclude
that the effects of orally administered DEHP on repro-
duction and fetal development were dose-dependent and
were influenced by the duration ofphthalate administra-
tion.
The teratogenic potential ofplasma soluble extracts of
polyvinyl chloride in rats was studied by Garvin et al.
(17). Aplasmaconcentration ofapproximately 185 ,ug/mL
DEHP was obtained by utilizing two different PVC for-
Table 2. Effect of DEHP/MEHP on reproduction and fetal
toxicity in mice and rabbitsa.
Route of
Species Sex administration Principal findings
Mouse Male IP Early fetal death and
semisterility
Rabbit Female IV Nonteratogenic
Mouse Female PO Nonteratogenic
Mouse Female PO Neural tube defects
Mouse Female PO Absence oftails
Mouse Female PO Decreased fetal
Mouse Female PO weights
Mouse Female PO Exencephaly, clubfoot
Teratogenic
aModified from Thomas (1).
Table 3. Effect of DEHP/MEHP on reproduction and fetal
toxicity in various studies on female rats.a
Route of
administration Principal findings
IP Fetal resorptions, fetal deaths, and decreased fe-
tal size
PO No effect upon fertility
PO Decreased fetal weight and increased fetal re-
sorptions
IP Reduced conception and increased fetal deaths
IP Adverse effect upon implantation and parturi-
tion, and excessive hemorrhaging and fetal re-
tention
IV No teratogenic or embryotoxic effects
IV Nonteratogenic
PO Nonteratogenic
PO Nonteratogenic
aModified from Thomas (1).
mulations and extracting them with sterile rat plasma.
When the DEHP-extracted plasma solutions were ad-
ministered IV into pregnant rats, no teratogenic or em-
bryotoxic effects were observed. The levels of DEHP
leached fromplastics posed noteratogenicrisks, and only
very high doses could induce changes inthe reproductive
system oflaboratory animals (17).
Thomas et al. (18,19) reported that monoethylhexyl
phthalate (MEHP) injected into previously artificially in-
seminated female rabbits at criticalintervals during ges-
tation caused no significant teratogenic effects. The
administration of MEHP did not affect the size of the
fetus, as evidenced by no changes in the crown-rump or
transumbilical measurements.
The teratogenic potential ofplasma-soluble extracts of
DEHP-plasticized PVC in rats was also reported by Le-
wandowski et al. (20). No differences were recorded in
the growth rates or in the general behavior ofeither the
control or the DEHP-treated groups. The incidence of
skeletal, visceral, and gross external defects among off-
spring was similar for both treated and control groups.
Lewandowski et al. (20) concluded that during the "crit-
ical period" of organogenesis, plasma extracts of PVC
plastics were not teratogenic when administered IV to
pregnant rats.
Yagi et al. (21) examined the teratogenic potential of
both DEHP and MEHP in mice. The oral administration
of DEHP in doses representing 1/6 or 1/3 of the acute
LD50 on day 7 of gestation led to 100% fatality of all
fetuses. Similartoxic effects were observed with MEHP
Thegrossabnormalities includedexencephaly, openeyelid
and club foot. Skeletal abnormalities occurred in the
skull, cervical and thoracic bones.
When Ruddick et al. (22) evaluated the teratogenic
potential of MEHP in the rat, no skeletal defects were
noted in the fetuses. Both MEHP-treated and control
groups exhibited some disturbances in the placement of
the sternebrae plates. No visceral anomalies were noted.
When DEHP or di-n-butyl phthalate (DBP) was ad-
ministered in the diet of pregnant mice, the major ter-
atogenic effects observed were neural tube defects (ex-
encephaly and spina bifida) (23,24). DEHP and DBP
caused intrauterine growth retardation and delayed os-
sification. High doses were embryotoxic and possibly ter-
atogenic in mice. The maximum nonembryotoxic doses of
these phthalates in mice were more than 2000 times the
estimated level of human intake through the food chain
(24).
The finding that DEHP inhibited hepatic sterologe-
nesis to agreater extent in male than in pregnant female
rats led Bell (25) to suggest that pregnant rats may be
less sensitive than nonpregnant rats to the effects of
DEHP because ofits partitioning into the fetus. Uptake
by the fetus could effectively dilute the DEHP concen-
tration in the maternal liver.
A single IP injection of dimethoxyethyl phthalate
(DMEP) to pregnant rats led to embryopathy, including
fetal deaths and fetal resorptions (26). Hydrocephalus
interna, skeletal deformities and appendicular malfor-
mations were caused by DMER DMEP also caused a
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Table 4. Gonadal toxicity of some phthalate acid esters (PAEs)a.
Species PAE Toxicity
Rat DEHP, MEHP, DOP +
Mouse DBP, DEHP +
Guinea pig DBP, DEHP +
Ferret DEHP +
Hampster DBP, DEHP
aModified from Gangolli (30) and Thomas (10).
significant decrease in fetal zinc levels suggesting that
this divalent ion may play a role in PAE-induced tera-
togenesis in the rat (26).
In mice, a single injection of DEHP on day 7 of ges-
tation caused a reduction in the body weight of living
mouse fetuses. There was no significant change in the
number of live fetuses and no gross and/or skeletal an-
omalies. Higher doses produced some fetotoxicity, a re-
lationship that was dose-dependent (27).
Studies by Wolkowski-Tyl et al. (28,29) revealed an
interesting comparative findingregardingthe teratogen-
icityofDEHPinratsandinmice. DEHP wasteratogenic
when administered to mice (28) in the feed during the
entire gestation period at high doses, but DEHP was not
teratogenic when administered to rats (29).
The majority of investigations of teratogenicity have
been undertaken in either mice or rats. PAE-induced
teratogenicity seems to occur at high doses in either the
nervous system or the skeletal system. Clearly, the
amounts that humans could potentially be exposed to
bear little relevance to the large doses employed in lab-
oratory animal experiments.
Testicular Effects
Gangolli and his colleagues have not only written an
excellentreview ontheeffectsofdifferentphthalates upon
gonadal function (30), but his presentation at this con-
ference(31)hasshedfurtherinsightintohowthese chem-
icals affect testicular morphology and zinc levels. At least
fourdifferent phthalates, studied in at least five different
species, have been investigated with respect to gonadal
toxicity (Table 4). Table 5 reveals the effects caused by
DEHP and/or MEHP while Table 6 depicts the action of
certain other phthalates upon gonadal function.
Phthalate-induced testicular injury in animals was in-
itially reported by Schaffer et al. (32), wherein dietary
concentrations of 0.075, 1.5, and 5.0% DEHP led to tu-
bular atrophy and testicular degeneration resembling se-
nile changes. Harris et al. (33) also found occasional in-
cidence of tubular atrophy in rats fed DEHP Calley et
al. (34) found that daily intraperitoneal administration
(250 mg/kg body weight) of DEHP or di(methoxyethyl)
phthalate in mice for 6 weeks significantly reduced the
relative testicular weight.
The oral administration of DBP at daily dose levels of
500 and 1000 mg/kg significantly reduced relative testes
weight (35). The correspondingmonoester (MBP) caused
even more marked reduction in testes weight (35,36).
Testicularlesions produced by DBP and MBPresembled
Table 5. Effect of DEHP and MEHP on the male reproductive
system.a
Species Agent
Rat
Rat
Ferret
Rat
Rat
Mouse
Rat
Mouse
Rat
Rat
Rat
DEHP
DEHP
DEHP
DEHP
DEHP
DEHP
DEHP
MEHP
MEHP
DEHP
DEHP
Effect
Testicular degeneration
Early fetal death and semisterility
Testicular degeneration
Testes histological damage
Testes weight
t Testosterone
Zinc
Testicular atrophy
Testosterone
t Testes weight
Zinc
Testes weight
t Testosterone
Zinc
Testes weight
Testes zinc
Testes weight
Changes in testes enzyme
aModified from Thomas (1)
thosefollowing DEHPtreatment. Thatthemechanism(s)
involved in DBP-induced testicular injury resulted not
from the accumulation ofmetabolites or the formation of
covalent adducts in testicular tissue is shown by the fact
that metabolic disposition studies following oral admin-
istration of 14C-labeled DBP showed no evidence of ac-
cumulationofradioactivityinthegonads. Testicularatro-
phydidnotappeartobemediatedbychangesinandrogen
synthesis or the availability ofgonadotrophins (30). Uri-
naryzinclevelsfollowing DBPtreatmentwereincreased.
Studies using 65Zn showed that DBP or MBP treatment
led to a marked increase in the urinary excretion of ra-
dioactivity and a decrease in 65Zn associated with tes-
ticular tissue (30). Additionally, the loss oftesticular zinc
in DBP-treated rats was accompanied by a decrease in
the activities of alcohol dehydrogenase and carbonic an-
hydrase.
Gray and Butterworth (37) showed in a 90-day toxicity
studyinrats that DEHPcausedtesticularatrophy. Sem-
Table 6. Effects of other phthalate acid esters (PAEs) on the
male reproductive system.a
Species PAE Effect
Rat DOP Decreased tests weight
Rat DMP - Testes weight
- t Zinc excretion
Rat MEHP, MBP,Testicular atrophy
MIBP
- Zinc
t Testosterone
Mouse MEHP, MBP,- 4 Testosterone
MIBP
- T Testicular weight
Rat DEHP, DA79P - Testicular weight
Rat DBP, MBP Testes damage
Hamster DBP, MBP No gonadal effect
Rat PA - Sperm motility
aModified from Thomas (1).
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Table 7. Effect of DEHP (1000 or 2000 mg/kg daily x 5, PO) on
immature (less than 100 g body weight) or mature (greater than
2000 g body weight) rats.a
(% of control)
Daily dose, mg/kg Immature rats Mature rats
Controlb 100 100
1000 58 94
2000 50 91
aData of K. A. Curto, unpublished observations.
bPeanut oil.
iniferous tubular atrophy, comprising aloss ofspermatids
and spermatocytes, occurred when young (4-week-old)
rats were given 10 daily doses ofDEHP Somewhat older
rats (e.g., 10- and 15-week-old) showed less testicular
damage or none at all. Somewhat comparable findings
were obtained in ourlaboratory by K. A. Curto, wherein
she demonstrated that gonadal atrophy was more pro-
nounced inthe testes ofthe immature rat (Table 7). Gray
and Butterworth (37) studied other phthalates and re-
ported anincidence ofgonadaltoxicity SuchPAE-induced
changes in testicular morphology were not affected by
the simultaneous administration of testosterone (38).
When young male rats were intubated (800 mg/kg daily,
x4) with mono-n-butyl esters of ortho-phthalic, iso-
phthalic, or terephthalic acid, only the ortho ester pro-
duced gonadal atrophy. Foster et al. (38) indicated that
in order for a phthalate to cause testicular atrophy, the
ester moiety must be in the ortho position and ofspecific
chainlength. Onlythose esters producingtesticulardam-
age caused concomitant decreases in gonadal zinc levels.
Later studies by Foster et al. (36) sought to explain
gonadal toxicity on the basis of species differences, par-
ticularly with respect to urinary metabolites. In both
rats and hamsters, the major urinary metabolite de-
tected after the oral administration with either di-n-bu-
tylphthalate ornono-n-butyl phthalate was aglucuronide
form of the monophthalate. The urinary levels of uncon-
jugated mono-n-butyl phthalate were about three times
greater in rats than in hamsters, suggesting that the
free form of the PAE may be more gonadotoxic.
Zinc deficiency depresses testicular growth, inhibits
sex accessory organweight, andproduces severe atrophy
of germinal epithelium (39,40). Experimentally induced
zinc deficiency in man causes oligospermia and can ad-
versely affect testicular function. Such gonadal toxicities
can be reversed by restoring adequate amounts of zinc
to the diet (41). Some phthalates cause a reduction in
reproductive organ zinc. Rat testicular zinc levels are
lowered by dietary DEHP or dietary MEHP (42) (see
Tables 5 and 6). A number of dietary constituents, in-
cluding calcium and phytate, interfere with zinc absorp-
tion (39). The exact mechanism ofgonadal zinc depletion
is unknown, but it may be explained by the formation of
a zinc-phthalate complex similar to that described by
Foster et al. (36). Curto and Thomas (43) and Agarwal
(44), have confirmed the relationship between zinc and
testicular atrophy induced by DEHP DEHP adminis-
tered orally to rats maintained on a low-zinc diet caused
an additive gonadotoxic effect. Interestingly enough,
phthalic anhydride reportedly exerts an action upon go-
nadotropin (45).
Last, it should be mentioned that DEHP in the diet
(6000 or 12,000 ppmfor 103weeks)fedtorats canactually
decrease the incidence of testicular tumors (46). These
DEHP-treated rats also exhibited lower incidence of pi-
tuitary tumors, although the relationship to diet is not
known.
Neonatal
Surprisingly little is known about the ability of PAEs
to be transferred to offspring (47). Radioactivity was
recovered from fetal tissues following treatment of ma-
ternal rats (48). Followinginjections ofMEHP into preg-
nant rabbits, aqueous homogenates obtained from either
the placental or the uterus contained less than ,ug/mL
(19). Likewise, MEHP levels in rabbit fetuses were found
to contain less than 1 ,ug/mL. In neonatal rats previously
injected with MEHP, very little PAE was detected in
their livers (19). Bell et al. (49) suggested that DEHP
can cross the placental barrier, as evidenced by inhibition
ofsterologenesis in the brain and in the liver offetal and
suckling rats from dams previously fed with this phthal-
ate. Subsequent reports (50) indicated that fetuses taken
by caesarean section from pregnant rats fed DEHP (be-
ginning 5 to 10 days after conception) exhibited an im-
pairment ofsterologenesis inbrainand liver. Also, ifdams
exposed to DEHP during gestation and also during the
postnatal period, are permitted to nurse their naturally
born offspring, hepatic sterologenesis in pups is reduced
(50).
Hillman et al. (51) attempted to identify DEHP in hu-
manneonataltissues afterumbilical catheterization alone
or with administration ofblood products. Determination
Table 8. Effects of a single IP injection of MEHP in peanut oil administered at 3 days of age to neonatal rats.a
Mean organ weights, mgb
Dose, mg/kg Liver Kidney Cerebral cortex Lung
Sham 1722 ± 95 485 ± 33 766 ± 29 502 ± 28
Peanut oil vehicle 1807 ± 95 501 ± 31 780 ± 27 480 ± 27
12.3 1788±95 516±31 788±27 482±27
24.5 1659± 95 458±31 768 ±27 474 ±27
49.2 1734 ± 95 476 ± 31 771 ± 27 492 ± 27
aAnimals were sacrificed at weaning (21 days of age).
bMean ± SD of at least 10 animals. Data of Thomas and Northup (52).
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of DEHP levels in neonatal heart and gastrointestinal
tissue revealed that those infants that had been previ-
ously catheterized or received large amounts of blood
products exhibited higher levels of plasticizer than did
controls (51).
An examination of fetoplacental metabolism in the
pregnant rat previously injected with dimethoxyethyl
phthalate (DMEP) suggested that there was a rapid
transfer of the parent compound to the fetus across the
placenta. DMEP caused a significant decrease inthe zinc
content ofthe fetus (26).
The metabolism and phannacokinetics of different
PAEshas beenstudied inanumberofspecies (47). Little
attention has been focused on the neonate with respect
tothemetabolismofthephthalates. Itmightbeexpected
thatboththedevelopinghepaticandrenalmetabolicpath-
ways do not possess the same clearance capacities as the
adult.
The effects of a single injection of MEHP upon the
neonatal rat are depicted in Table 8. It can be seen that
under these experimental conditions there were no
MEHP-induced changes in the gravimetric response in
the liver, kidney, cerebralcortex, orlung. Itisnoteworthy
that despite the three relativelylarge dose regimens em-
ployed, there were no significant differences in hepatic
weights.
Summary
Severalstudieshave examined theteratologicpotential
of DEHP, MEHP, and other phthalates. Teratogenicity
is evident in some species, but only at very high doses.
Testicular damage canbeproduced with several different
chemical entities of the phthalates. Gonadal zinc defi-
ciency is an observation consistent with phthalate-in-
duced gonadal toxicity.
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